ArticleJHEP reports : innovation in hepatology2025

Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC.

Jinyeong Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.